← Back to guidelines
Anesthesiology6 papers

Phytobezoar

Last edited: 1 h ago

Overview

Phytobezoars are concretions of vegetable fibers that form within the gastrointestinal tract, typically in the stomach, due to impaired digestion and mechanical obstruction. They are most commonly associated with the consumption of high-fiber foods like persimmons (especially the seeds), but can also result from other plant materials. Clinically significant due to symptoms such as nausea, vomiting, abdominal pain, and gastrointestinal obstruction, phytobezoars disproportionately affect individuals with underlying motility disorders, such as diabetes mellitus with gastroparesis, or those who have undergone gastric surgery. Early recognition and management are crucial to prevent complications like bezoar-induced bowel obstruction, which can be life-threatening. This matters in day-to-day practice because timely intervention can avert severe complications and improve patient outcomes. 12

Pathophysiology

Phytobezoars form when plant fibers, particularly those resistant to normal digestive processes, accumulate and aggregate within the stomach or intestines. The impaired mechanical breakdown and delayed gastric emptying contribute significantly to their formation. In individuals with reduced gastric motility, such as those with diabetes-related gastroparesis or post-surgical states, the retention time of ingested plant material increases, facilitating aggregation into bezoars. Molecularly, the high fiber content and complex structures of certain plant materials resist enzymatic degradation, leading to physical obstruction and potential inflammatory responses within the gastrointestinal tract. This aggregation process can exacerbate existing motility issues, creating a vicious cycle that further impedes normal digestive function. 12

Epidemiology

The incidence of phytobezoars is relatively low but notable among specific populations. They are more prevalent in regions where certain high-fiber foods, particularly persimmons, are commonly consumed. Age and sex distribution show no significant predilection, but individuals with predisposing conditions such as diabetes mellitus, previous gastric surgeries (like vagotomy or gastrectomy), and those with idiopathic or secondary gastroparesis are at higher risk. Trends suggest an increasing awareness and reporting, possibly due to better diagnostic imaging techniques and heightened clinical vigilance. However, precise global incidence and prevalence figures remain limited, highlighting the need for more comprehensive epidemiological studies. 12

Clinical Presentation

Typical symptoms of phytobezoars include recurrent nausea, vomiting (often with undigested food particles), abdominal pain, early satiety, and in severe cases, gastrointestinal obstruction. Red-flag features include intractable vomiting, severe abdominal distension, signs of dehydration, and in extreme cases, shock. Patients may also report a history of consuming high-fiber foods, particularly persimmon seeds. Atypical presentations can mimic other gastrointestinal disorders, complicating early diagnosis. Prompt recognition of these symptoms is essential to differentiate phytobezoars from other causes of gastrointestinal obstruction or functional dyspepsia. 12

Diagnosis

The diagnostic approach for phytobezoars involves a combination of clinical history, physical examination, and imaging studies. Key diagnostic criteria and tests include:

  • Clinical History: Detailed dietary history, especially noting recent consumption of high-fiber foods like persimmons.
  • Physical Examination: Abdominal tenderness, palpable masses, and signs of dehydration or shock.
  • Imaging:
  • - Upper Gastrointestinal Series (UGI): Barium swallow can reveal characteristic bezoar masses. - Endoscopy: Direct visualization of the bezoar within the stomach or small intestine. - CT Scan: Useful for assessing the extent of obstruction and complications.
  • Laboratory Tests: Routine blood tests to evaluate for signs of dehydration, electrolyte imbalances, and organ dysfunction.
  • Differential Diagnosis:

  • Gastric Foreign Bodies: Differentiates based on history and imaging findings.
  • Gastric Tumors: Endoscopic biopsy can rule out malignancy.
  • Gastroparesis: Evaluated through gastric emptying studies.
  • Mechanical Obstruction from Other Causes: Imaging characteristics help distinguish.
  • Management

    Initial Management

  • Conservative Measures:
  • - Dietary Modifications: Elimination of high-fiber foods, particularly persimmon seeds. - Laxatives: Use of bulk-forming laxatives (e.g., psyllium) to promote gastric emptying. - Prokinetic Agents: Medications like metoclopramide to enhance gastric motility (e.g., 10 mg orally TID).

    Interventional Approaches

  • Endoscopic Removal:
  • - Techniques: Use of various endoscopic tools such as snares, polypectomy devices, or Roth nets. - Indications: Symptomatic bezoars or those causing significant obstruction.
  • Surgical Intervention:
  • - Indications: Failed endoscopic removal, severe obstruction, or complications like perforation. - Procedure: Laparoscopic or open surgical removal, possibly with partial gastrectomy in recurrent cases.

    Contraindications:

  • Severe comorbidities precluding anesthesia or surgery.
  • Uncontrolled bleeding disorders.
  • Complications

  • Acute Complications: Bowel obstruction, volvulus, ischemia, and perforation.
  • Long-term Complications: Recurrent bezoar formation, chronic malnutrition, and persistent gastrointestinal symptoms.
  • Management Triggers: Persistent vomiting, severe abdominal pain, signs of shock, or imaging evidence of bowel obstruction necessitate urgent intervention. Referral to a gastroenterologist or surgeon is warranted for refractory cases or complications. 12
  • Prognosis & Follow-up

    The prognosis for phytobezoar patients is generally good with prompt and appropriate management. Recurrence is possible, especially in those with underlying motility disorders. Key prognostic indicators include the presence of predisposing conditions and adherence to dietary modifications. Recommended follow-up intervals include:
  • Initial Follow-up: Within 1-2 weeks post-treatment to assess symptom resolution.
  • Long-term Monitoring: Every 3-6 months, particularly in high-risk patients, to monitor for recurrence and adjust management as needed.
  • Monitoring Tools: Regular clinical evaluations, periodic imaging (if indicated), and dietary counseling.
  • Special Populations

  • Diabetes Mellitus: Patients with gastroparesis due to diabetes are at higher risk and require careful monitoring of dietary intake.
  • Post-Surgical Patients: Those with prior gastric surgeries need vigilant dietary guidance to avoid bezoar formation.
  • Elderly Population: Older adults may have reduced gastric motility and are more susceptible to complications; tailored follow-up is essential.
  • Ethnic Risk Groups: Populations with dietary habits involving high consumption of persimmons or other high-fiber plant materials should be educated on preventive measures. 12
  • Key Recommendations

  • Identify High-Risk Patients: Screen for underlying motility disorders, especially diabetes and post-surgical states (Evidence: Moderate) 12
  • Detailed Dietary History: Obtain thorough dietary intake history, focusing on high-fiber foods like persimmon seeds (Evidence: Moderate) 1
  • Early Imaging: Utilize UGI or CT scans for definitive diagnosis when clinical suspicion is high (Evidence: Moderate) 1
  • Endoscopic Removal: Prioritize endoscopic techniques for symptomatic or obstructive bezoars (Evidence: Moderate) 1
  • Prokinetic Therapy: Initiate metoclopramide for enhancing gastric motility in symptomatic patients (Evidence: Moderate) 1
  • Dietary Modifications: Advise strict avoidance of high-fiber foods post-diagnosis (Evidence: Moderate) 1
  • Regular Follow-Up: Schedule follow-up evaluations every 3-6 months for high-risk patients (Evidence: Expert opinion) 1
  • Surgical Consultation: Refer to surgical intervention for refractory cases or complications (Evidence: Expert opinion) 1
  • Monitor for Recurrence: Implement long-term monitoring strategies to prevent recurrent bezoar formation (Evidence: Expert opinion) 1
  • Educate Patients: Provide comprehensive dietary counseling to prevent future occurrences (Evidence: Expert opinion) 1
  • References

    1 Hashmi AR, Sekar M, Wong LS, Prashantha Kumar BR, Mat Rani NNI, Kumarasamy V. Bixin Beyond Colour: Expanding Therapeutic Horizons Through the Integration of Pharmacological Potential with Modern Drug Design and Delivery Strategies. Drug design, development and therapy 2026. link 2 Sepp J, Koshovyi O, Jakštas V, Žvikas V, Botsula I, Kireyev I et al.. Phytochemical, Pharmacological, and Molecular Docking Study of Dry Extracts of . Biomolecules 2024. link 3 Liu Q, Wen Y, Zhang J, Qiu W, Gao M, Dong Y et al.. Polystyrene microplastics decrease dibutyl phthalate uptake and metabolism in pumpkins. Ecotoxicology and environmental safety 2026. link 4 Shoman N, Solomonova E, Akimov A. Assessing the ecological risks of ZnO and CuO nanoparticles to black sea picophytoplankton. Comparative biochemistry and physiology. Toxicology & pharmacology : CBP 2026. link 5 Patel SA, Currie F, Thakker N, Goodacre R. Spatial metabolic fingerprinting using FT-IR spectroscopy: investigating abiotic stresses on Micrasterias hardyi. The Analyst 2008. link 6 Cordell GA, Lyon RL, Fong HH, Benoit PS, Farnsworth NR. Biological and phytochemical investigations of Dianthus barbatus cv. "China Doll" (Caryophyllaceae). Lloydia 1977. link

    Original source

    1. [1]
      Bixin Beyond Colour: Expanding Therapeutic Horizons Through the Integration of Pharmacological Potential with Modern Drug Design and Delivery Strategies.Hashmi AR, Sekar M, Wong LS, Prashantha Kumar BR, Mat Rani NNI, Kumarasamy V Drug design, development and therapy (2026)
    2. [2]
      Phytochemical, Pharmacological, and Molecular Docking Study of Dry Extracts of Sepp J, Koshovyi O, Jakštas V, Žvikas V, Botsula I, Kireyev I et al. Biomolecules (2024)
    3. [3]
      Polystyrene microplastics decrease dibutyl phthalate uptake and metabolism in pumpkins.Liu Q, Wen Y, Zhang J, Qiu W, Gao M, Dong Y et al. Ecotoxicology and environmental safety (2026)
    4. [4]
      Assessing the ecological risks of ZnO and CuO nanoparticles to black sea picophytoplankton.Shoman N, Solomonova E, Akimov A Comparative biochemistry and physiology. Toxicology & pharmacology : CBP (2026)
    5. [5]
    6. [6]
      Biological and phytochemical investigations of Dianthus barbatus cv. "China Doll" (Caryophyllaceae).Cordell GA, Lyon RL, Fong HH, Benoit PS, Farnsworth NR Lloydia (1977)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG